Andrew J. Murphy, EVP Research at REGENERON PHARMACEUTICALS, INC. (REGN), sold 13,490 shares at $626.51 ($8.5M) on 2022-02-15, disclosed to the SEC on 2022-02-16.
Open-market sale of $8.5M REGN by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $626.79 | 6,460 | $4.0M | 47.8% |
| 2 | $622.09 | 99 | $62K | 0.7% |
| 3 | $622.09 | 99 | $62K | 0.7% |
| 4 | $625.90 | 50 | $31K | 0.4% |
| 5 | $626.51 | 421 | $264K | 3.1% |
| 6 | $626.51 | 421 |
| $264K |
| 3.1% |
| 7 | $627.49 | 630 | $395K | 4.7% |
| 8 | $627.49 | 630 | $395K | 4.7% |
| 9 | $628.62 | 520 | $327K | 3.9% |
| 10 | $628.62 | 520 | $327K | 3.9% |
| 11 | $629.35 | 533 | $335K | 4.0% |
| 12 | $629.35 | 533 | $335K | 4.0% |
| 13 | $630.41 | 434 | $274K | 3.2% |
| 14 | $630.41 | 434 | $274K | 3.2% |
| 15 | $631.67 | 185 | $117K | 1.4% |
| 16 | $631.67 | 185 | $117K | 1.4% |
| 17 | $632.71 | 289 | $183K | 2.2% |
| 18 | $632.71 | 289 | $183K | 2.2% |
| 19 | $633.54 | 220 | $139K | 1.6% |
| 20 | $633.54 | 220 | $139K | 1.6% |
| 21 | $634.43 | 159 | $101K | 1.2% |
| 22 | $634.43 | 159 | $101K | 1.2% |
| Total | $628.13 avg | 13,490 | $8.5M | 100% |
| Filing → |
| REGN | SELL | 2024-03-15 | $11.0M | — | Filing → |
| REGN | SELL | 2023-12-06 | $10.6M | — | Filing → |
| REGN | SELL | 2023-11-15 | $10.3M | — | Filing → |